Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Steatosis associates with insulin resistance and may even predict type 2 diabetes and cardiovascular complications. Because muscular insulin resistance relates to myocellular fat deposition and disturbed energy metabolism, we hypothesized that reduced hepatic ATP turnover (fATP) underlies insulin resistance and elevated hepatocellular lipid (HCL) contents. RESEARCH DESIGN AND METHODS: We measured hepatic fATP using 31P magnetic resonance spectroscopy in patients with type 2 diabetes and age- and body mass–matched controls. Peripheral (M and M/I) and hepatic (suppression of endogenous glucose production) insulin sensitivity were assessed with euglycemic-hyperinsulinemic clamps. RESULTS: Diabetic individuals had 29% and 28% lower peripheral and hepatic insulin sensitivity as well as 42% reduced fATP than controls. After adjusting for HCL, fATP correlated positively with peripheral and hepatic insulin sensitivity but negatively with waist circumference, BMI, and fasting plasma glucose. Multiple regression analysis identified waist circumference as an independent predictor of fATP and inorganic phosphate (PI) concentrations, explaining 65% (P = 0.001) and 56% (P = 0.003) of the variations. Hepatocellular PI primarily determined the alterations in fATP. CONCLUSIONS: In patients with type 2 diabetes, insulin resistance relates to perturbed hepatic energy metabolism, which is at least partly accounted for by fat depots.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In these studies, hepatic ATP production more strongly associated with hepatic than peripheral insulin sensitivity (130, 131).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [130]
In the citing paper
“However, as in muscle, 31 P-NMR measurements of hepatic mitochondrial ATP production reveal 23%-26% decreased ATP production in T2D individuals compared with age-and weightmatched nondiabetic controls (130, 131).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 3×
“We studied elderly volunteers who had a mean age of ~60 years, whichmight result in lower fATP analogous to data on myocellular fATP (8).”
BackgroundResultMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“In skeletal muscle, insulin resistance relates not only to elevated lipids but also to impaired rates of phosphorylation (flux throughATP synthesis, fATP), asmeasured by (31)P MRS in elderly (6) type 2 diabetic patients (7), their insulin-resistant firstdegree relatives (8), and nondiabetic individuals with elevated p…”
BackgroundNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664 · cited 2×
“In type 2 diabetes, insulin resistance develops as a result of inherited factors as well as from acquired factors that result in glucolipotoxicity due to chronic elevation of FFAs, triglycerides, or glucose (2,3).”
BackgroundDietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440 · cited 1×
“A short-term high-fat diet also leads to insulin resistance in liver, but not in skeletal muscle (17), whereas a hypocaloric diet decreases both hepatic fat content and insulin resistance within 48 h (18).”
BackgroundThe prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis
Rankinen, T., Kim, S.-Y., Pérusse, L., Després, J.-P., & Bouchard, C. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800929 · Cited by 414 · cited 1×
“Of note, waist circumference is the best anthropometric marker of abdominal visceral fat (19), which suggests, but does not prove, a role of visceral fat for hepatic energy metabolism.”
BackgroundMechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance
Roden, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0190 · Cited by 405
Self-citationMuscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243 · cited 5×
“A 20% dextrose infusion labeled with D-[6,6-(2)H2]glucose (2% enriched) according to the hot-glucose infusion protocol was periodically adjusted to maintain euglycemia (7).”
BackgroundMethodInfluentialSelf-citationIncreased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
Brehm, A., Krssak, M., Schmid, A. I., Nowotny, P., Waldhäusl, W., & Roden, M. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1286 · Cited by 239
Self-citationAbnormal Hepatic Energy Homeostasis in Type 2 Diabetes†
Szendroedi, J., Chmelik, M., Schmid, A. I., Nowotny, P., Brehm, A., Krssak, M., Moser, E., & Roden, M. (2009) · Hepatology · doi:10.1002/hep.23093 · Cited by 204
Self-citationVendemiale, G., Grattagliano, I., Caraceni, P., Caraccio, G., Domenicali, M., Dall'Agata, M., Trevisani, F., Guerrieri, F., Bernardi, M., & Altomare, E. (2001) · Hepatology · doi:10.1053/jhep.2001.23060 · Cited by 160
Alterations in Hepatic Mitochondrial Compartment in a Model of Obesity and Insulin Resistance
Raffaella, C., Francesca, B., Italia, F., Marina, P., Giovanna, L., & Susanna, I. (2008) · Obesity · doi:10.1038/oby.2008.10 · Cited by 123
Kacerovsky-Bielesz, G., Chmelik, M., Ling, C., Pokan, R., Szendroedi, J., Farukuoye, M., Kacerovsky, M., Schmid, A. I., Gruber, S., Wolzt, M., et al. (2009) · Diabetes · doi:10.2337/db08-1240 · Cited by 75
Self-citationIs liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
Loria, P., Lonardo, A., & Targher, G. (2008) · Clinical Science · doi:10.1042/cs20070311 · Cited by 72
Schmid, A. I., Chmelík, M., Szendroedi, J., Krššák, M., Brehm, A., Moser, E., & Roden, M. (2008) · NMR in Biomedicine · doi:10.1002/nbm.1207 · Cited by 67 · cited 5×
“A 3-dimensional k-space weighted chemical shift imaging sequence (field of view: 20 3 20 3 20 cm, repetition time: 1 s, bandwidth: 5 kHz, 2,048 acquisitions in 34 min) was applied, reconstructed, and quantified offline using custom-made software in combination with jMRUI/ AMARES, as described (12,14).”
BackgroundMethodResultSelf-citationThe Diabetes Prevention Program Research Group (2006) · Obesity · doi:10.1038/oby.2006.246 · Cited by 67
Chmelík, M., Schmid, A. I., Gruber, S., Szendroedi, J., Krššák, M., Trattnig, S., Moser, E., & Roden, M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21762 · Cited by 53
Self-citationSaturation-transfer studies of ATP-Pi exchange in isolated perfused rat liver
Thoma, W. J., & Uǧurbil, K. (1987) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(87)90043-0 · Cited by 42
Tilg, H., & Moschen, A. R. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833a87cc · Cited by 37
Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes
Brøns, C., & Vaag, A. A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.177758 · Cited by 25
Butterworth, P., & Younus, M. J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90167-x · Cited by 14
Formation of adenosine 5'-phosphoroglycerol from ATP and glycerol by rat liver plasma membranes.
Ryan, J., Rogers, G. N., Toscano, D. G., & Storm, D. R. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40607-7 · Cited by 9
Cited by
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
“This link between DAG-mediated activation of nPKCs and muscle insulin resistance has been replicated in human studies (Itani et al., 2002; Szendroedi et al., 2011).”
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
“, 2009) and flux through ATP synthase (Schmid et al., 2011), pointing to a possible role of circulating glucose.”
Self-citationMechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Kawano, Y., & Cohen, D. E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0758-5 · Cited by 969
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Self-citation
Metadata
- Authors
- Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M.
- Affiliations
- Medical University of Vienna (AT)
- Deutsches Diabetes-Zentrum e.V. (DE)
- MR Center of Excellence, Medical University of Vienna, Vienna, Austria
- Corresponding author
- Roden, Michael
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 448-453
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024365
- OpenAlex
- W2171705653
- Cited by
- 212
- References
- 24
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 9 · 2022: 16 · 2021: 17 · 2020: 16 · 2019: 14 · 2018: 11 · 2017: 11 · 2016: 18 · 2015: 16 · 2014: 17 · 2013: 17 · 2012: 11
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- GlaxoSmithKline
- European Foundation for the Study of Diabetes
- Deutsche Forschungsgemeinschaft (SFB 575, Project 13)
- Oesterreichische Nationalbank (OENB 11459)
- European Association for the Study of Diabetes
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, hepatic insulin sensitivity, hepatic steatosis, inorganic phosphate, hepatic energy metabolism, waist circumference, hyperinsulinemic-euglycemic clamp, 31P NMR
- MeSH terms
- Adenosine Triphosphate, Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Energy Metabolism, Fatty Liver, Female, Humans, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Phosphorus Isotopes, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.